Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis

被引:16
|
作者
Moya, Diana [1 ,2 ]
Baker, Susan S. [1 ,2 ]
Liu, Wensheng [1 ,2 ]
Garrick, Michael [1 ,3 ]
Kozielski, Rafal [4 ]
Baker, Robert D. [1 ,2 ]
Zhu, Lixin [1 ,2 ]
机构
[1] SUNY Buffalo, Dept Pediat, Buffalo, NY 14214 USA
[2] Women & Childrens Hosp Buffalo, Digest Dis & Nutr Ctr, Buffalo, NY USA
[3] SUNY Buffalo, Dept Biochem, Buffalo, NY USA
[4] SUNY Buffalo, Women & Childrens Hosp Buffalo, Dept Pathol, Buffalo, NY 14214 USA
关键词
Transferrin; Catalase; Hydrogen peroxide; Transferrin receptor 2; NHANES; FATTY LIVER-DISEASE; TRANSFERRIN RECEPTOR 2; INSULIN-RESISTANCE; HEPATIC IRON; HEREDITARY HEMOCHROMATOSIS; HYPOTRANSFERRINEMIC MICE; HEPCIDIN EXPRESSION; GENE-EXPRESSION; HFE; FIBROSIS;
D O I
10.1016/j.clnu.2014.06.011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background & aims: Iron may be an important factor in the pathogenesis of non-alcoholic steatohepatitis (NASH) as it catalyzes the production of potent reactive oxygen species. We aim to examine iron status in pediatric NASH. Methods: Serum indices of NASH patients (N = 36) were compared to those in the U.S. National Health and Nutrition Examination Survey database (N = 802). Iron related gene expression was examined in NASH livers and normal livers, using microarray and quantitative real-time PCR (10 NASH livers and 6 controls). Transferrin and catalase expression were also examined in hydrogen peroxide treated HepG2 cells. Results: Serum iron concentration (P < 0.01) and soluble transferrin receptor 1 (P < 0.0001) were decreased while serum ferritin was elevated in NASH patients (P < 0.01). No detectable iron was observed in NASH liver by Perls' Prussian blue staining. Transferrin (P < 0.01) and transferrin receptor 2 (P < 0.01) mRNA were elevated in NASH patients. Of particular interest, transferrin mRNA was positively correlated with catalase mRNA (r = 0.9338, P < 0.0001). H2O2 treatment of HepG2 cells induced mRNA expression of transferrin and catalase. Conclusions: Pediatric NASH patients exhibited decreased serum iron concentration and no detectable iron was observed in any NASH liver by Perls' Prussian blue staining. These changes are consistent with the facts that most NASH patients are obese and exhibit chronic inflammation. In line with a status of iron deficiency, gene expression studies suggested decreased expression of transferrin and transferrin receptor 2 in NASH livers. Induction of transferrin by H2O2, and consequently, decreased iron absorption, suggests a novel mechanism for iron deficiency in NASH patients. (C) 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:549 / 556
页数:8
相关论文
共 50 条
  • [21] Combined alcoholic and non-alcoholic steatohepatitis
    Wandji, Line Carolle Ntandja
    Gnemmi, Viviane
    Mathurin, Philippe
    Louvet, Alexandre
    JHEP REPORTS, 2020, 2 (03)
  • [22] A rabbit model of non-alcoholic steatohepatitis reveals a novel mechanism of hepatic iron deposition
    Otogawa, Kohji
    Kinoshita, Kohji
    Fujii, Hideki
    Shiga, Ryouko
    Nakatani, Kazuki
    Ikeda, Kazuo
    Ikura, Yoshihiro
    Hato, Fumihiko
    Kawada, Norifumi
    HEPATOLOGY, 2006, 44 (04) : 569A - 569A
  • [23] Pathogenesis and novel treatment options for non-alcoholic steatohepatitis
    Wong, Vincent Wai-Sun
    Chitturi, Shiv
    Wong, Grace Lai-Hung
    Yu, Jun
    Chan, Henry Lik-Yuen
    Farrell, Geoffrey C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01): : 56 - 67
  • [24] Ammonia: A novel target for the treatment of non-alcoholic steatohepatitis
    Thomsen, Karen Louise
    De Chiara, Francesco
    Rombouts, Krista
    Vilstrup, Hendrik
    Andreola, Fausto
    Mookerjee, Rajeshwar P.
    Jalan, Rajiv
    MEDICAL HYPOTHESES, 2018, 113 : 91 - 97
  • [25] A Novel Mouse Model of Accelerated Non-Alcoholic Steatohepatitis
    Malhotra, P.
    Han, E.
    Ooka, K.
    Muthusamy, S.
    Gill, R.
    Dudeja, P.
    Aloman, C.
    Alrefai, W.
    FASEB JOURNAL, 2015, 29
  • [26] Non-Alcoholic Steatohepatitis: From Pathophysiology to Novel Therapies
    Jahn, Daniel
    Rau, Monika
    Wohlfahrt, Julia
    Hermanns, Heike M.
    Geier, Andreas
    DIGESTIVE DISEASES, 2016, 34 (04) : 356 - 363
  • [27] Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
    Povero, Davide
    Feldstein, Ariel E.
    DIABETES & METABOLISM JOURNAL, 2016, 40 (01) : 1 - 11
  • [28] Non-alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches
    Schuppan, Detlef
    Schattenberg, Jorn M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 68 - 76
  • [29] Identification of a gene-pathway associated with non-alcoholic steatohepatitis
    Rubio, Angel
    Guruceaga, Elizabeth
    Vazquez-Chantada, Mercedes
    Sandoval, Juan
    Martinez-Cruz, L. Alfonso
    Segura, Victor
    Sevilla, Jose L.
    Podhorski, Adam
    Corrales, Fernando J.
    Torres, Luis
    Rodriguez, Manuel
    Aillet, Fabienne
    Ariz, Usue
    Martinez Arrieta, Felix
    Caballeria, Juan
    Martin-Duce, Antonio
    Lu, Shelly C.
    Martinez-Chantar, M. Luz
    Mato, Jose M.
    JOURNAL OF HEPATOLOGY, 2007, 46 (04) : 708 - 718
  • [30] Drugs and non-alcoholic steatohepatitis
    Farrell, GC
    STEATOHEPATITIS (NASH AND ASH), 2001, 121 : 132 - 139